COVID-19 in ocrelizumab-treated people with multiple sclerosis

BACKGROUND: There are limited data on the impact of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on people with multiple sclerosis (MS). OBJECTIVE: To better understand SARS-CoV-2 infection in ocrelizumab-treated people with MS. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Richard, Whitley, Louise, Fitovski, Kocho, Schneble, Hans-Martin, Muros, Erwan, Sauter, Annette, Craveiro, Licinio, Dillon, Paul, Bonati, Ulrike, Jessop, Nikki, Pedotti, Rosetta, Koendgen, Harold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772086/
https://www.ncbi.nlm.nih.gov/pubmed/33482590
http://dx.doi.org/10.1016/j.msard.2020.102725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772086/
https://www.ncbi.nlm.nih.gov/pubmed/33482590
http://dx.doi.org/10.1016/j.msard.2020.102725

Ejemplares similares